[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection]
[一项 II 期、单臂、开放标签、多中心临床研究,旨在评估索非布韦联合利巴韦林治疗 2 型基因型慢性丙型肝炎病毒感染患者的疗效和安全性]
期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.issn.1007-3418.2019.05.006
Gao, Y H; Li, G M; Jin, Q L; Zhao, Y R; Jia, Z S; Mao, X R; Yang, Y F; Shang, J; Wang, G C; Xie, W; Wu, S M; Zhang, M X; Hou, J L; Li, D L; Nan, Y M; Guan, Y J; Zhu, C X; Yuan, Y Z; Wei, L